Aptamer is in the spotlight of next-generation technology that can replace antibodies

Aptamer is a single-stranded oligonucleotides that specifically bind to targets in a three-dimensional structures and specifically bind to target molecules.
Aptamer can be extensively used for the development of research tools, diagnosis and therapeutics purpose.
Currently, Aptamer is gaining many attention as an alternative to satisfying the unsolved needs of antibodies, showing steady demands in various application areas.